Definitive Contract 75F40122C00130

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $248,725 Firm Fixed Price contract to Hartford Hospital, a non-profit 830-bed hospital in Hartford, Connecticut. The contract was awarded under the FDA's Broad Agency Announcement (BAA) seeking advanced research and development proposals to support regulatory science and innovation across multiple areas. Under this contract, Hartford Hospital is conducting comparative efficacy research on antibiotic...

The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price Definitive Contract to Hartford Hospital, a non-profit hospital in Hartford, Connecticut, with a potential value of $249,794.00. The contract is for research related to "Metallo-B-Lactamase Resistance in Enterobacterales: Is It Time to Rethink Our In Vitro Assessment Tools?". This contract was issued under a Broad Agency Announcement (BAA) that solicits advanced research and...

The Department of Health and Human Services Food and Drug Administration awarded a $249,999.00 definitive contract to Hartford Hospital, a non-profit hospital organization, to conduct research and development in support of regulatory science and innovation. This contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science for fiscal year 2021, which solicits proposals across eight areas of regulatory science to modernize FDA functions. The contract does not have...

This federal contract award, valued at $450,714.35, was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Hartford Hospital, a non-profit healthcare institution and subsidiary of Hartford Healthcare Corporation. The contract is for emergency medical simulation training services and does not have a set-aside designation. This award demonstrates Hartford Hospital's expertise in providing advanced medical research and simulation services to federal...

The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $994,647.76 Purchase Order contract to Diant Pharma Inc. for a Pilot-Scale Nanoparticle Continuous Manufacturing System. Performance will take place in Storrs, Connecticut under firm fixed pricing terms. The contract begins on May 17, 2022 and concludes on November 29, 2023. Diant Pharma Inc. will provide pilot-scale continuous manufacturing equipment and services for developing nanoparticle drug...

The Food and Drug Administration (FDA) awarded a $61,572.71 definitive, firm fixed-price contract to the Connecticut Department of Agriculture's Bureau of Agricultural Development and Research Preservation Division, a state government entity, to conduct regulatory inspections of animal food manufacturing facilities in Connecticut. The contract, which runs from September 2021 to September 2026, supports the division's legal authority and experience in assessing compliance with federal regulations...

The University of Connecticut has been awarded a definitive contract by the Department of Health and Human Services Food and Drug Administration to continue processing liposomal nanoparticles as reference materials for drug product development. With a potential value of $349,364, this time and materials contract does not have a set-aside designation and is to be completed by May 31, 2023. As the prime contractor, the University will utilize its expertise in nanotechnology and materials...

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $308,625.00 purchase order contract to NMD Group, LLC, a woman-owned small business, to support the FDA's planning for real-world data and real-world evidence related to COVID-19. The contract has a completion date of September 7, 2021 and is structured as a labor hours contract. This contract award appears to be part of the FDA's efforts to accelerate planning and utilization of real-world data and...

This is a $973,150.35 definitive, firm fixed price contract awarded by the Food and Drug Administration (FDA) to the University of Connecticut (UConn) for a study on the "Impact of Polymer Attributes on the Performance of In Situ Forming Implants." The contract has a completion date of September 9, 2023 and was awarded on March 6, 2020. UConn, a non-profit educational institution, will leverage its expertise in scientific research and specialized services to support this FDA study....

The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $45,824 delivery order contract to DCT, Incorporated (doing business as DCT Inc.) to replace the domestic steam hot water system at its facility located in Jefferson, Arkansas. The firm fixed price contract runs from May 16, 2022 through September 7, 2022 and will provide for the replacement of the existing steam hot water system at the HHS FDA site in Jefferson, Arkansas. No subcontractors or set...